TrianglePUBLICATIONS · 10856103
Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2000 Jun
- First author
- Baker KS
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Baker KS
- type
- Author
- name
- Anderson JR
- type
- Author
- name
- Link MP
- type
- Author
- name
- Grier HE
- type
- Author
- name
- Qualman SJ
- type
- Author
- name
- Maurer HM
- type
- Author
- name
- Breneman JC
- type
- Author
- name
- Wiener ES
- type
- Author
- name
- Crist WM
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Baker KS
- type
- Author
- name
- Anderson JR
- type
- Author
- name
- Link MP
- type
- Author
- name
- Grier HE
- type
- Author
- name
- Qualman SJ
- type
- Author
- name
- Maurer HM
- type
- Author
- name
- Breneman JC
- type
- Author
- name
- Wiener ES
- type
- Author
- name
- Crist WM
- type
- Author
- bibliography ids
- nci-bib-d1e6beb986186d9c85dd0ad6
- book metadata
- content sha256
- f94ca79f9da2433723d09a2d2fb9de3d0b07e4f641464bfe831fcf8f9a1e1e3c
- document type
- citation
- dois
- 10.1200/JCO.2000.18.12.2427
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:10856103
- immutable id
- pubmed:10856103@f94ca79f9da2433723d09a2d2fb9de3d0b07e4f641464bfe831fcf8f9a1e1e3c
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 12
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2427-34
- volume
- 18
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 10856103
- provenance
- batch id
- c98b220a79580c9840c7
- provider
- NCBI PubMed ESummary
- record sha256
- 9ebf5b9dac4d44766b47e4803a2b0960236960830cce460a1c5c67014ced6064
- response sha256
- d5d875b1aa149faaecebc150cec3cacc2861402b103226e5006d2b0ce5dccd23
- retrieved at
- 2026-09-09T23:45:37.924736+00:00
- publication date
- display
- 2000 Jun
- precision
- month
- year
- 2000
- publication types
- Clinical Trial
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV.
Preserved source evidence · Not medical advice